Pulseless Electrical Activity Clinical Features Diagnosis and Management Guide
medicine

Pulseless Electrical Activity Clinical Features Diagnosis and Management Guide

Pulseless Electrical Activity (PEA)


1. Definition

Pulseless Electrical Activity (PEA) is a cardiac arrest rhythm characterized by organized electrical activity on ECG without a palpable pulse or measurable cardiac output. Electrical depolarization occurs, but mechanical contraction is absent or ineffective, resulting in circulatory collapse.

> PEA is not a shockable rhythm.


2. Pathophysiology

PEA occurs when electromechanical dissociation develops due to:

  • Severely reduced preload, afterload mismatch, myocardial pump failure, or obstructed cardiac filling/outflow
  • Cellular hypoxia, acidosis, or metabolic derangements impairing excitation–contraction coupling
  • Catastrophic mechanical causes (tamponade, massive PE, tension pneumothorax)

Electrical conduction persists, but stroke volume → zero.


3. Etiology (Reversible Causes – “Hs and Ts”)

Hs

  1. Hypovolemia – hemorrhage, dehydration
  2. Hypoxia – airway obstruction, respiratory failure
  3. Hydrogen ion (Acidosis) – lactic, renal failure
  4. Hypo-/Hyperkalemia – renal failure, drugs
  5. Hypothermia – exposure, cold environments
  6. Hypoglycemia (considered in some protocols)

Ts

  1. Tension pneumothorax
  2. Cardiac tamponade
  3. Toxins – beta-blockers, calcium channel blockers, opioids, TCAs
  4. Thrombosis (coronary) – acute MI
  5. Thrombosis (pulmonary) – massive pulmonary embolism
  6. Trauma – severe blunt or penetrating injury

4. Clinical Features

  • Unresponsiveness
  • Absent carotid/femoral pulse
  • Apnea or agonal respirations
  • ECG shows organized rhythm (sinus, junctional, idioventricular)
  • No blood pressure, no cardiac output

5. Diagnosis

PEA is a clinical diagnosis during cardiac arrest.

Key Diagnostic Points

  • ECG rhythm without pulse
  • Confirm with pulse check ≤10 seconds
  • Point-of-care ultrasound (POCUS) (highly valuable):

* Distinguish true PEA (no cardiac activity)

* Identify reversible causes (tamponade, massive PE, hypovolemia)


6. Differential Diagnosis

  • Asystole (no electrical activity)
  • Ventricular fibrillation
  • Pulseless ventricular tachycardia
  • Profound cardiogenic shock with weak pulse
  • Pseudo-PEA (minimal cardiac output detectable only by ultrasound)

7. Management (ACLS – Stepwise)

Immediate Actions

  1. High-quality CPR

* Rate: 100–120/min

* Depth: 5–6 cm

* Full recoil, minimal interruptions

  1. Airway & Oxygen

* 100% oxygen

* Early advanced airway if skilled

  1. IV/IO Access

Drug Therapy

Epinephrine

  • Indication: All PEA cardiac arrests
  • Dose:

* Adults: 1 mg IV/IO every 3–5 minutes

* Pediatrics: 0.01 mg/kg IV/IO (1:10,000), max 1 mg

  • Mechanism:

* α1: peripheral vasoconstriction → ↑ coronary & cerebral perfusion

* β1: ↑ myocardial contractility

  • Pharmacokinetics: Rapid onset, short half-life (~2–3 min)
  • Adverse Effects: Tachyarrhythmias, myocardial ischemia (post-ROSC)
  • Contraindications: None in cardiac arrest
  • Monitoring: Rhythm checks every 2 min, ETCO₂
  • Counseling: Not applicable (emergency drug)

Critical Principle

👉 Identify and treat reversible causes (Hs & Ts)

Drugs alone will not reverse PEA without correcting the cause.


8. Cause-Specific Management

| Cause | Targeted Treatment |

| -------------------- | ------------------------------------------------------------- |

| Hypovolemia | Rapid IV crystalloids, blood products |

| Hypoxia | Secure airway, ventilate with 100% O₂ |

| Acidosis | Effective CPR, ventilation; sodium bicarbonate only if severe |

| Hyperkalemia | Calcium gluconate, insulin + glucose, beta-agonists |

| Tension pneumothorax | Immediate needle decompression |

| Cardiac tamponade | Emergency pericardiocentesis |

| Massive PE | Thrombolysis or embolectomy |

| Coronary thrombosis | Emergent PCI after ROSC |

| Toxins | Antidotes (naloxone, glucagon, calcium), supportive care |

| Hypothermia | Active rewarming |


9. Role of Ultrasound in PEA

  • Confirms cardiac standstill vs pseudo-PEA
  • Guides fluid resuscitation
  • Detects tamponade, PE, pneumothorax
  • Prognostic value (persistent standstill → poor prognosis)

10. Prognosis

  • Overall survival is poor compared to shockable rhythms
  • Better outcomes when:

* PEA is secondary to reversible causes

* Early CPR and early epinephrine

* POCUS-guided management

  • Prolonged true PEA with no reversible cause → very high mortality

11. Post-ROSC Care

  • Maintain SpO₂ 94–98%
  • Avoid hypotension (MAP ≥65 mmHg)
  • Targeted temperature management if comatose
  • Treat underlying cause definitively
  • Neurologic monitoring

12. Key Exam & Clinical Pearls

  • PEA = electrical activity WITHOUT pulse
  • Not shockable
  • CPR + epinephrine + fix the cause
  • Always think Hs and Ts
  • Ultrasound is a game-changer

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Pulseless electrical activity is a cardiac arrest rhythm in which organized electrical activity is seen on ECG but there is no palpable pulse or effective cardiac output.
No, pulseless electrical activity is a non-shockable rhythm and should not be treated with defibrillation.
Death in PEA occurs due to failure of mechanical cardiac contraction despite preserved electrical activity, leading to complete circulatory collapse.
The common reversible causes are summarized as Hs and Ts, including hypovolemia, hypoxia, acidosis, hypo- or hyperkalemia, hypothermia, tension pneumothorax, cardiac tamponade, toxins, thrombosis (coronary or pulmonary), and trauma.
Immediate high-quality CPR along with early administration of intravenous or intraosseous epinephrine and rapid identification of reversible causes.
The recommended adult dose is 1 mg IV or IO every 3–5 minutes during resuscitation.
Defibrillation is ineffective because PEA does not involve chaotic electrical activity but rather a failure of mechanical contraction.
Pseudo-PEA refers to organized electrical activity with minimal cardiac contraction detectable only by ultrasound, without a palpable pulse.
Bedside ultrasound helps identify reversible causes such as cardiac tamponade, massive pulmonary embolism, severe hypovolemia, and distinguishes true PEA from pseudo-PEA.
Severe hyperkalemia is a frequent and life-threatening cause of PEA in patients with renal failure.
End-tidal CO2 monitoring helps assess CPR quality and prognosis, with persistently low values indicating poor perfusion and low chance of ROSC.
PEA generally has a poorer prognosis than ventricular fibrillation or pulseless ventricular tachycardia, especially if no reversible cause is identified.
Yes, massive myocardial infarction or mechanical complications such as ventricular rupture can lead to PEA.
The most important principle is rapid identification and correction of reversible causes while continuing high-quality CPR.
Termination is considered when prolonged high-quality resuscitation fails to achieve ROSC and no reversible causes are identified, following institutional and ethical guidelines.